Sign Up Today and Learn More About Geneoscopy Stock
Invest in or calculate the value of your shares in Geneoscopy or other pre-IPO companies through EquityZen's platform.
Geneoscopy Stock
Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.
About Geneoscopy Stock
Founded
2015
Headquarters
Saint Louis, MO, US
Industries
Software, Artificial Intelligence, Data and Analytics
Geneoscopy Press Mentions
Stay in the know about the latest news on Geneoscopy
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
biospace • Feb 09, 2026
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
businesswire • Feb 07, 2026
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
morningstar • Feb 07, 2026
Colorectal cancer screening method and device
patents • Feb 01, 2026
Compositions and methods for ibd patients using stool-derived eukaryotic …
patents • Feb 01, 2026
Geneoscopy Management
Leadership team at Geneoscopy
Board Of Director
Drew Dennison
Co-Founder and Chief Executive Officer
Andrew Barnell
Join now and verify your accreditation status to gain access to:
- Geneoscopy Current Valuation
- Geneoscopy Stock Price
- Geneoscopy Management
- Available deals in Geneoscopy and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Geneoscopy Cap Table and Funding History by Share Class and Liquidity Preferences
- Geneoscopy Revenue and Financials
- Geneoscopy Highlights
- Geneoscopy Business Model
- Geneoscopy Risk Factors
- Geneoscopy Research Report from SACRA Research
Trading Geneoscopy Stock
How to invest in Geneoscopy stock?
Accredited investors can buy pre-IPO stock in companies like Geneoscopy through EquityZen funds. These investments are made available by existing Geneoscopy shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Geneoscopy stock?
Shareholders can sell their Geneoscopy stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
